Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects

Alternative Therapies in Health and Medicine

Volumn 13, Issue 6, 2007, Pages 44-48

  Roza, James M ^a   Xian Liu, Zheng ^b   Guthrie, Najla ^c  

^a SourceOne Global Partners   (United States)

^b Geronutra   (United States)

^c KGK Synergize Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOTRIENOL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FLAVONOID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; MALE; OPEN STUDY; BLOOD; CARDIOVASCULAR DISEASE; CITRUS FRUIT; DRUG COMBINATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CITRUS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FLAVONOIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; TOCOTRIENOLS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 38449092034     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. American Heart Association. What Your Cholesterol Levels Mean. Available at: www. americanheart.org/presenter.jhtml?identifier=183. Accessed August 24, 2007.
2. Your Guide to Lowering Your Cholesterol With TLC. Washington, DC: US Dept of Health and Human Services; 2005. NIH publication 06-5235.
3. Cook NC, Samman S. Flavonoids - chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 1996;7(2):66-76.
4. Borradaile NM, Carroll KK, Kurowska EM. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids. 1999;34(6):591-598.
5. Kurowska EM, Manthey JA, Hasegawa S, Manners GD, Vandenberg TA. Cholesterol-lowering effects of citrus juices, flavonoids and limonoids. Paper presented at: International Conference and Exhibition on Nutraceuticals and Functional Foods; September 13-17, 2000; Houston, TX.
6. Kurowska EM, Banh C, Hasegawa S, Manners GD. Regulation of Apo B production in HepG2 cells by citrus limonoids. In: Berhow MA, Hasegawa S, eds. Citrus Limonoids: Functional Chemicals in Agriculture and Foods. ACS Symposium Series. Washington, CD: American Chemical Society; 2000:175-184.
7. Kurowska EM, Borradaile NM. Hypocholesterolemic effects of dietary citrus juices in rabbits. Nutr Res. 2000;20:121-129.
8. Kurowska EM, Spence JD, Jordan J, et al. HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr. 2000;72(5):1095-1100.
9. Manthey JA, Guthrie N, Grohmann K. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem. 2000;8(2):135-153.
10. Kumamoto H, Matsubara Y, Iizuka Y, Okamoto K, Yokoi K. Structure and hypotensive effect of flavonoid glycosides in orange (Citrus sinensis OSBECK) peelings. Agric Biol Chem. 1986;50(3):781-783.
11. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc. 2000;75(4):369-380.
12. Lemos VS, Freitas MR, Muller B, Lino YD, Queiroga CE, Côrtes SF. Dioclein, a new nitric oxide-and endothelium-dependent vasodilator flavonoid. Eur J Pharmacol. 1999;386(1):41-46.
13. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1993;268(15):11230-11238.
14. Guthrie N, Kurowska EM. Anti-cancer and cholesterol-lowering activities of tocotrienols. In: Wildman REC, ed. Handbook of Nutraceuticals and Functional Foods. Boca Raton, FL: CRC Press; 2000:269-280.
15. Black TM, Wang P, Maeda N, Coleman RA. Palm tocotrienols protect ApoE +/-mice from diet-induced atheroma formation. J Nutr. 2000;130(10):2420-2426.
16. Qureshi AA, Bradlow BA, Brace L, et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids. 1995; 30(12):1171-1177.
17. Quereshi AA, Bradlow BA, Salser WA, Brace LD. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. Nutr Biochem. 1997;8(5):290-298.
18. Mensink RP, van Houvelingen AC, Kromhout D, Hornstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr. 1999;69(2):213-219.
19. Newaz MA, Nawal NN. Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). Clin Exper Hypertens. 1999;21(8):1297-1313.
20. Theriault A, Chao JT, Wang Q, Gapor A, Adeli K. Tocotrienol: a review of its therapeutic potential. Clin Biochem. 1999;32(5):309-319.
21. Smogorzewski M. The myopathy of statins. J Ren Nutr. 2005;15(1):87-93.
22. Silver M, Langsjoen P, Szabo S, Patil H, Zelinger A. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. Am J Cardiol. 2004;94(10):1306-1310.
23. Nawarskas JJ. HMG-CoA reductase inhibitors and coenzyme Q10. Cardiol Rev. 2005;13(2):76-79.
24. Manthey JA, Grohmann K, Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem. 2001;8(2):135-153.
25. Jamil H, Gordon DA, Eustice DC, et al. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc Natl Acad Sci U S A. 1996;93(21):11991-11995.
26. Gordon DA. Recent advances in elucidating the role of the microsomal triglyceride transfer protein in apolipo-protein B lipoprotein assembly. Curr Opin Lipidol. 1997;8(3):131-137.
27. Kurowska EM, Manthey JA, Casaschi A, Theriault AG. Modulation of HepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin. Lipids. 2004;39(2):143-151.
28. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3- hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1993;268(15):11230-11238.
29. Pearce BC, Parker RA, Deason ME, Quereshi AA, Wright JJ. Hypercholesterolemic activity of synthetic and natural tocotrienols. J Med Chem. 1992;35(20):3595-3606.
30. Quereshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM, Elson CE. Dietary alpha-to-copherol attenuates the impact of gamma-tocotrienol on Hepatic 3-hydroxy- 3-methyl-glutaryl coenzyme A reductase activity in chickens. J Nutr. 1996;126(2):389-394.
31. Theriault A, Chao JT, Wang Q, Gapor A, Adeli K. Tocotrienol: a review of its therapeutic potential. Clin Biochem. 1999;32(5):309-319.
32. Kurowska EM, Laidlaw M, Barber J, et al. Sytrinol™, a novel cholesterol-lowering supplement. Paper presented at: Canadian Federation of Biological Sciences Annual Meeting; June 21-25, 2005; Guelph, Ontario, Canada.